Autism research, IVF care, GLP-1 side effects: Morning Rounds

2 2 minutes read

Pickleball Injuries: A Growing Concern in the Sports World

Recent reports have highlighted a concerning trend in the world of sports: pickleball injuries are on the rise. As someone with a background in tennis and a former ballkid at a prestigious tournament, I have strong opinions about this emerging sport. In my view, pickleball is a nuisance and should be banned.

Putting sports opinions aside, a pressing question has emerged that warrants reader feedback. Can a new scale truly measure incessant thoughts about food? This question stems from the fact that individuals with obesity often experience debilitating thoughts about food. Telehealth company Ro has introduced a questionnaire aimed at measuring which obesity treatments can help quiet these “food noise” thoughts to enhance patient care.

While this scale presents a potential opportunity for patients, some critics view it as a mere sales pitch from a company profiting from treating obesity. STAT’s Elaine Chen delves into the science behind obesity and examines the adoption of this scale by researchers and clinicians, despite the lack of conclusive evidence regarding its effectiveness.

Industry officials in the fertility sector are celebrating the Trump administration’s efforts to make in vitro fertilization (IVF) more affordable. The administration’s recent initiatives, including partnering with drugmaker EMD Serono to lower drug prices commonly used in IVF, have raised hopes for increased accessibility and reduced costs for patients seeking fertility treatments.

However, concerns have been raised about potential cuts in home care services for elderly and disabled populations following reductions in federal funding for state Medicaid programs. A recent report sheds light on the murky algorithms governing eligibility for these programs, revealing political motivations and uncertainties surrounding eligibility criteria.

Amidst the influx of new autism studies, evaluating the credibility and relevance of these findings poses a significant challenge. While some studies, like the one linking increased autism incidence to air pollution during pregnancy, may seem compelling, the presence of confounding variables can undermine the validity of such claims. As a science journalist, it is essential to discern which studies warrant attention and why some may not meet the criteria for publication.

One individual’s experience with off-label use of GLP-1s for addiction sheds light on the limitations of Trump’s low-cost plan to make these drugs more accessible. Despite promising results in addiction treatment, access to these drugs remains restricted for purposes beyond obesity treatment. Expanding access to GLP-1s for addiction could provide much-needed relief for individuals grappling with substance dependence.